Navigation Links
ViroPharma to Present at the BIO CEO & Investor Conference
Date:2/5/2008

EXTON, Pa., Feb. 5 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced that Vincent Milano, chief financial officer and chief operating officer of ViroPharma, will present at the BIO CEO & Investor Conference at 12:30 P.M. ET on Monday, February 11, 2008. The conference is being held at the Waldorf=Astoria, in New York.

ViroPharma's presentation will be webcast live for investors through http://www.viropharma.com and available through February 28, 2008.

About ViroPharma Incorporated

ViroPharma Incorporated is a biopharmaceutical company dedicated to the development and commercialization of products that address serious diseases treated by physician specialists and in hospital settings. ViroPharma commercializes Vancocin(R), approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus, including methicillin- resistant strains (for prescribing information, please download the package insert at http://www.viropharma.com/docs/Vancocin_pi_2007.htm). ViroPharma currently focuses its drug development activities in viral diseases including cytomegalovirus (CMV) and hepatitis C (HCV). For more information on ViroPharma, visit the company's website at http://www.viropharma.com.


'/>"/>
SOURCE ViroPharma Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. ViroPharma to Present at Two Upcoming Healthcare Conferences
2. ViroPharma Provides 2008 Outlook
3. Imagenetix Inc. to Present at Noble Small Cap Financial Conference on August 21, 2007
4. Avicena Group to Present at Noble Financial Conference
5. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
6. Strategic Diagnostics to Present at Two Upcoming Investor Conferences
7. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
8. CEL-SCI to Present at the Noble Financial Conference
9. Lexicon Presents Class of Compounds Modulating TPH1, the Target for its LX1031 Investigational Drug for Irritable Bowel Syndrome
10. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
11. Strategic Diagnostics Updates Roth Conference Presentation Time
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... , May 21, 2013  Synthetic Biologics, Inc. (NYSE ... and treatment of serious infectious diseases, announced today that ... 2 nd Annual Marcum LLP MicroCap Conference on Thursday, ... at the Grand Hyatt Hotel. Mr. Riley is scheduled ... live webcast of Synthetic Biologics, presentation can be accessed by ...
(Date:5/21/2013)... May 21, 2013 NANONEX CORPORATION, ... solutions , today announced the successful delivery and ... system, the NX-M200B, to a major Japanese manufacturing ... a fully-automated, production-ready, advanced nanoimprint lithography tool that ... wafer and substrate sizes and types. Based on ...
(Date:5/21/2013)... SoundConnect is pleased to announce the release ... in Canada. Lync is the next generation of ... and organizations to collaborate and communicate much more easily ... the United States. With the progressive rollout of Lync ... Canada, SoundConnect now offers a complete Microsoft Lync solution ...
(Date:5/20/2013)... May 20, 2013 , ... Research Service (ARS) in treatment of mastitis ... , Trials to begin in the second half ... technology company Phosphagenics Limited (ASX: POH, OTCQX: ... (USDA) Agricultural Research Service (ARS) to develop and trial ...
Breaking Biology Technology:Synthetic Biologics to Present at the 2nd Annual Marcum LLP MicroCap Conference 2Nanonex Announces the Shipment and Installation of an Innovative Nanoimprint Lithography System for Fully Automated Manufacturing 2SoundConnect Announces Microsoft Lync Release in Canada 2SoundConnect Announces Microsoft Lync Release in Canada 3Phosphagenics Signs Research Agreement with the Agricultural Research Service 2
... , PHILADELPHIA and LONDON, July 22 ... compendium of pharmaceutical research and development statistics, the CMR International ... offers extended content including patent information and emerging trends in ... R&D Factbook provides the data that R&D companies need ...
... , CHICAGO, July 22 Research presented ... an assay developed by Abbott for simultaneous detection of both HIV antigens ... this study compared to HIV antibody-only assays. Earlier detection was shown ... , "The ability to use a blood test to diagnose ...
... , , ROCKVILLE, Md., ... ) today announced that the U.S. Government has exercised its option ... Strategic National Stockpile, to be delivered over a three-year period, beginning ... $151 million from this award as deliveries are completed. ...
Cached Biology Technology:Thomson Reuters Announces 2009 Edition of the CMR International Pharmaceutical R&D Factbook 2Abbott HIV Test Demonstrates Earlier Disease Detection 2Abbott HIV Test Demonstrates Earlier Disease Detection 3Human Genome Sciences Announces New Order for Raxibacumab (ABthrax(TM)) from U.S. Government 2Human Genome Sciences Announces New Order for Raxibacumab (ABthrax(TM)) from U.S. Government 3Human Genome Sciences Announces New Order for Raxibacumab (ABthrax(TM)) from U.S. Government 4Human Genome Sciences Announces New Order for Raxibacumab (ABthrax(TM)) from U.S. Government 5Human Genome Sciences Announces New Order for Raxibacumab (ABthrax(TM)) from U.S. Government 6
(Date:5/20/2013)... compound abundant in the Mediterranean diet takes away cancer ... a very specific step in gene regulation, this compound ... as scheduled. , One way that cancer cells thrive ... to die on a regular cycle that is subject ... Ohio State University researchers, found that a compound in ...
(Date:5/20/2013)... New Geology articles posted online ... cover a wide swath of geoscience subdisciplines, including ... and paleobotany. Locations studied include Siberia; the Sumatran ... Apuane, Italy; Ukraine; Mars; and the Southeastern U.S. ... Rubies, jadeite, and plate tectonics;, 2. The clear ...
(Date:5/18/2013)... AGA Research Foundation is honored to announce the first ... Cancer, which will support Andrew D. Rhim, MD, from ... Pennsylvania, Philadelphia, as he furthers his research on the ... progression. , "The AGA Research Foundation is humbled to ... and AGA Legacy Society members," said Nicholas F. LaRusso, ...
Breaking Biology News(10 mins):The compound in the Mediterranean diet that makes cancer cells 'mortal' 2The compound in the Mediterranean diet that makes cancer cells 'mortal' 3New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 2New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 3New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 4New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 5New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 6New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 7New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 8New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 9New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 10New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 11AGA Research Foundation grant furthers digestive cancer research 2
... lines specifically tailored to match the nuclear DNA of patients, ... or spinal cord injury. , The research is being released ... non-profit science society, on the Science Express website on 19 ... of human disease in cells in the laboratory. The work ...
... of Science holds mixed blessings for scientists who follow ... study, conducted by scientists from Cincinnati Children's Hospital Medical ... Germany, reveals important evidence that tells us more about ... hand, scientists offer caution in regards to the side ...
... study has discovered that two chemical compounds may help ... without invasive gene therapy. Presented March 5 at the ... demonstrates that the new chemicals activate telomerase -- a ... them to continue destroying HIV-infected cells. , "The immune ...
Cached Biology News:Scientists generate patient-specific stem cells, Science study says 2Scientists generate patient-specific stem cells, Science study says 3Scientists generate patient-specific stem cells, Science study says 4Science study holds implications for gene therapy and stem cell biology 2Science study holds implications for gene therapy and stem cell biology 3Two chemicals boost immune cells' ability to fight HIV without gene therapy 2
CELLine System cultivation flask (for secreted products)...
... The mini incubation trays ... used to screen antigens that ... membrane. Each tray has eight ... channels that accommodate strips cut ...
... Plasma Immunodepletion Kit specifically removes 20 of ... or serum in preparation for further proteomics ... the plasma proteome whether you use one- ... or go straight to mass spectrometry. This ...
... first siRNA sequence design software in 2001, ... tools consistent with new experimental strategies and ... RNAi. With the introduction of our ... OligoEngine is pleased to offer the most ...
Biology Products: